Larráyoz, M.J.; Luri-Martin, P.; Mañu, A.; Churruca, O.; Gordillo, N.; Erdozain, I.; Esteban-Figuerola, A.; de Miguel, C.; Robles, D.; GarcÃa-Fortes, M.;
et al. From Sanger to Oxford Nanopore MinION Technology: The Impact of Third-Generation Sequencing on Genetic Hematological Diagnosis. Cancers 2025, 17, 1811.
https://doi.org/10.3390/cancers17111811
AMA Style
Larráyoz MJ, Luri-Martin P, Mañu A, Churruca O, Gordillo N, Erdozain I, Esteban-Figuerola A, de Miguel C, Robles D, GarcÃa-Fortes M,
et al. From Sanger to Oxford Nanopore MinION Technology: The Impact of Third-Generation Sequencing on Genetic Hematological Diagnosis. Cancers. 2025; 17(11):1811.
https://doi.org/10.3390/cancers17111811
Chicago/Turabian Style
Larráyoz, MarÃa José, Pablo Luri-Martin, Amagoia Mañu, Oihane Churruca, Natalia Gordillo, Irache Erdozain, Ada Esteban-Figuerola, Carlos de Miguel, Diego Robles, MarÃa GarcÃa-Fortes,
and et al. 2025. "From Sanger to Oxford Nanopore MinION Technology: The Impact of Third-Generation Sequencing on Genetic Hematological Diagnosis" Cancers 17, no. 11: 1811.
https://doi.org/10.3390/cancers17111811
APA Style
Larráyoz, M. J., Luri-Martin, P., Mañu, A., Churruca, O., Gordillo, N., Erdozain, I., Esteban-Figuerola, A., de Miguel, C., Robles, D., GarcÃa-Fortes, M., Rifón Roca, J., Alfonso-Pierola, A., Prósper, F., Ariceta, B., & Calasanz, M. J.
(2025). From Sanger to Oxford Nanopore MinION Technology: The Impact of Third-Generation Sequencing on Genetic Hematological Diagnosis. Cancers, 17(11), 1811.
https://doi.org/10.3390/cancers17111811
